Introduction to Cholinergic and Anti-cholinergic Drugs

1. Direct-acting Cholinergic Agonists

These drugs bind directly to and activate the cholinergic receptors (muscarinic or nicotinic) on the membranes of effector cells. Common examples include Bethanechol and Pilocarpine.

• Clinical Uses: Managing urological problems (like bladder atony) or reducing intraocular pressure in glaucoma.
• Side Effects: Because they stimulate the PNS, they can cause systemic effects such as sweating, salivation, nausea, and diarrhea.

2. Indirect-acting Cholinergic Agonists

Rather than binding to the receptor itself, these drugs target the enzyme Acetylcholinesterase (AChE). Under normal conditions, AChE breaks down ACh into acetate and choline to terminate the signal. Indirect agonists inhibit this enzyme, preventing the breakdown of endogenous ACh. This results in an increased concentration and longer duration of ACh at the synaptic cleft, leading to increased stimulation of the receptors.

• Clinical Uses: Treating Myasthenia Gravis (an autoimmune disease where antibodies destroy ACh receptors at the neuromuscular junction), Alzheimer’s disease, and bladder atony.

Exam Tip: The SLUDGEM Mnemonic When studying the side effects of cholinergic agonists, remember SLUDGEM. This represents the overstimulation of the parasympathetic system: Salivation, Lacrimation, Urination, Diaphoresis (sweating)/Diarrhoea, GI distress, Emesis (vomiting), and Miosis (constricted pupils).

Cholinergic Antagonists: Blocking the PNS

Cholinergic antagonists, also known as anti-cholinergics or "parasympatholytics," work by blocking the effects of acetylcholine. They effectively "lyse" or suppress the parasympathetic response.

While there are several types of blockers (including ganglionic and neuromuscular blockers), the most clinically significant for this topic are Muscarinic Receptor Antagonists. These drugs bind selectively to muscarinic receptors, preventing ACh from activating them.

Clinical Applications and Side Effects

Because these drugs inhibit the "rest and digest" functions, their side effects are often the exact opposite of the SLUDGEM symptoms:

• Uses: Pupil dilation (mydriasis), treating GI tract spasms (anti-spasmodic), managing motion sickness, and treating COPD.
• Side Effects: Dry mouth, blurred vision, tachycardia (increased heart rate), constipation, confusion, and hallucinations.

Summary and Clinical Context

To master this topic, you must be able to link the drug's mechanism to its physiological outcome.

Quick Check: Practice Question Question: What is the mechanism of action of indirect-acting cholinergic agonists? A. Bind to nicotinic receptor B. Bind to muscarinic receptor C. Block alpha adrenergic receptors D. Activate beta adrenergic receptors E. Inhibit acetylcholinesterase

Answer: E. Indirect-acting agonists do not bind to the receptor; they inhibit the enzyme that breaks down the neurotransmitter.

Finally, remember that these drugs exist in a delicate balance with the Adrenoreceptors (Alpha and Beta) of the Sympathetic Nervous System. For example, while cholinergic drugs might decrease heart rate, adrenergic agonists like $\beta_1$ agonists would increase it. Understanding this interplay is essential for comprehensive pharmacology.